Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

VFH vs VHT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VHT Wins Head-to-Head Institutional Verdict (1–0 across 6 Pillars · 1–1 Matrix Metrics)

VHT Overall Winner 6-Pillar Tally: VFH 0 – 1 VHT (5 Tie) Matrix Metrics: VFH 1 – 1 VHT

As of Nov 16, 2026, Vanguard Health Care ETF (VHT) is the stronger overall head-to-head candidate over Vanguard Financials ETF (VFH) in the Tradestie Institutional Equity Comparison Engine, winning 1–1 core matrix metrics and 1–0 across our 6-pillar institutional scorecard (led by Options & Positioning). VFH carries a Unified Composite Score of 46.2/100 (HOLD) at $140.62 (N/M Forward P/E, N/A operating margin), whereas VHT carries 40.4/100 (SELL) at $345.56 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While VFH currently prints a higher short-term Unified Composite Score (46.2/100 HOLD vs. VHT 40.4/100 SELL), VHT captures the overall institutional head-to-head verdict (1–1 matrix metrics and 1–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About VFH vs VHT
VFH NYSE Arca
Vanguard Financials ETF
Institutional Equity
$140.62
-0.83% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.53β · 21% Vol
Unified Composite Score
46.2 / 100 HOLD
Tech 33.0 Fund 43.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 55
RSI-14: 55.0 · SMA20: $138.79 · SMA50: $136.14
VHT NYSE Arca Head-to-Head Winner
Vanguard Health Care ETF
Institutional Equity
$345.56
-0.68% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.36β · 21% Vol
Unified Composite Score
40.4 / 100 SELL
Tech 27.0 Fund 34.0 Flow 52.0 Mom 21.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.4% over 20 days), RSI 61
RSI-14: 60.8 · SMA20: $341.08 · SMA50: $326.79

6-Pillar Scorecard Institutional Category Breakdown (VFH 0 – 1 VHT)

Columns: Metric · VFH · VHT
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning VHT
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile 16.4% (4th %ile) 18.3% (7th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral ACCUMULATION · Markup
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: VFH (1) vs VHT (1)
Institutional Metric VFH VHT Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
83% ($117–$146) 90% ($265–$355) Stronger Trend VHT
Beta / 30D Volatility
Risk Regime
0.53β · 21% Vol 0.36β · 21% Vol Lower Realized Risk Tie
Unified Institutional Score
Composite Signal
46.2 / 100 (HOLD) 40.4 / 100 (SELL) Higher Composite VFH
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VHT +1.27 pp
VFH: +4.36% · VHT: +5.63%
3M Horizon VHT +9.04 pp
VFH: -0.66% · VHT: +8.38%
6M Horizon VHT +16.39 pp
VFH: +10.93% · VHT: +27.32%
1Y Horizon VHT +12.64 pp
VFH: +9.14% · VHT: +21.78%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VFH vs VHT. Trailing 12-month operating profitability (VFH N/A vs VHT N/A) and valuation multiples (VFH N/M vs VHT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

VFH ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
VHT ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
VFH UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 16.4%
IV Percentile 4th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VFH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VHT CONSOLIDATION
62d in phase · OBV ACCUMULATION
Current IV 18.3%
IV Percentile 7th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact VHT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
VFH Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
VHT Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ VFH vs VHT Key Questions & Quantitative Answers

As of Nov 16, 2026, Vanguard Health Care ETF (VHT) is the stronger overall head-to-head candidate over Vanguard Financials ETF (VFH) in the Tradestie Institutional Equity Comparison Engine, winning 1–1 core matrix metrics and 1–0 across our 6-pillar institutional scorecard (led by Options & Positioning). VFH carries a Unified Composite Score of 46.2/100 (HOLD) at $140.62 (N/M Forward P/E, N/A operating margin), whereas VHT carries 40.4/100 (SELL) at $345.56 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While VFH currently prints a higher short-term Unified Composite Score (46.2/100 HOLD vs. VHT 40.4/100 SELL), VHT captures the overall institutional head-to-head verdict (1–1 matrix metrics and 1–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).

VFH and VHT split Growth & Scale metrics: VFH posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with VHT at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, VFH generates N/A in USD-normalized revenue versus N/A for VHT. In operating R&D and SG&A reinvestment, VFH deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for VHT.

VFH and VHT trade at balanced relative valuation multiples. VFH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas VHT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VFH (N/A ROE) versus VHT (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, VFH carries 16.4% implied volatility (4th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.53β · 21% Vol realized risk). By comparison, VHT carries 18.3% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.36β · 21% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.